BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2014 6:38:00 PM | Browse: 1409 | Download: 1576
Publication Name World Journal of Gastroenterology
Manuscript ID 9617
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Jie Wu, Lei Song, Dan-Yi Zhao, Bing Guo and Jing Liu
Funding Agency and Grant Number
Corresponding Author Lei Song, MS, Department of Medical Oncology, the Second Hospital of Dalian Medical University, Zhongshan Road 467, Dalian 116023, Liaoning Province, China. songlei_1975@126.com
Key Words Irinotecan; Gemcitabine; Transarterial chemoembolization; Hepatocellular carcinoma; Overall survival
Core Tip In the present study, we aimed to compare the efficacy of different chemotherapeutic agents during conventional transarterial chemoembolization (cTACE) in the treatment of unresectable hepatocellular carcinoma. Our study indicated that for patients treated with cTACE, the chemotherapeutic agent irinotecan (CPT-11) was significantly associated with improved overall survival and longer time to progression compared with gemcitabine or doxorubicin. There were no significant differences in clinical adverse events between the three agents. CPT-11 thus appears to be a promising agent when combined with cTACE for the treatment of hepatocellular carcinoma.
Publish Date 2014-08-20 18:38
Citation Wu J, Song L, Zhao DY, Guo B, Liu J. Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2014; 20(31): 10960-10968
URL http://www.wjgnet.com/1007-9327/full/v20/i31/10960.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i31.10960
Full Article (PDF) WJG-20-10960.pdf
Full Article (Word) WJG-20-10960.doc